Frequent hemodialysis at night may improve some outcomes for patients with end-stage kidney diseaseSeptember 19, 2007Patients who received hemodialysis at night six times a week for treatment of end-stage kidney disease had improvements on certain outcomes, including reduced need for blood pressure medications and improvement in selected quality of life measures, compared to patients who received conventional hemodialysis three times weekly, according to an article in the September 19 issue of JAMA. Despite advances in dialysis and medical therapies, patients with end-stage renal (kidney) disease (ESRD) have annual rates of death that exceed 15 percent. Cardiovascular disease, specifically heart failure or sudden death, is responsible for the majority of deaths, according to background information in the article. Some recent studies have suggested that nocturnal hemodialysis might improve clinical outcomes in ESRD patients. Bruce F. Culleton, M.D., M.Sc., formerly of the University of Calgary, Alberta, Canada, and colleagues conducted a study to determine the effects of frequent nocturnal hemodialysis compared with conventional hemodialysis on certain outcomes, including left ventricular (LV) mass, health-related quality of life (HRQOL), blood pressure and mineral metabolism. The randomized controlled trial was conducted at two Canadian university centers between August 2004 and December 2006. A total of 52 patients undergoing hemodialysis were recruited. Participants were randomly assigned to receive nocturnal hemodialysis six times weekly or conventional hemodialysis three times weekly.
"Our findings indicate that frequent nocturnal hemodialysis improves LV mass, systemic blood pressure, abnormalities of mineral metabolism, and possibly HRQOL compared with conventional thrice-weekly hemodialysis," the authors write. LV mass decreased by an average of 13.8 grams in the nocturnal hemodialysis group and increased by 1.5 grams in the conventional hemodialysis group, for a difference of 15.3 grams. Frequent nocturnal hemodialysis was associated with a reduction in or discontinuation of antihypertensive medications (16/26 patients in the nocturnal hemodialysis group vs. 3/25 patients in the conventional hemodialysis group). No benefit in anemia management was seen with nocturnal hemodialysis. "If it is found that nocturnal hemodialysis has a favorable cost-benefit profile compared with other dialysis therapies, then consideration should be given to expansion of nocturnal hemodialysis centers, specifically for patients who wish to trade a more demanding therapy for less cardiovascular risk and a potential of improved quality of life," the researchers conclude. JAMA and Archives Journals | |||||||||||||||||||||
|
Related Hemodialysis Current Events and Hemodialysis News Articles Scientists identify cell changes leading to impaired 'artificial kidney' function Molecular targets identified by a Spanish research team may hold the key to freedom for some sufferers of kidney disease. A new study published in Disease Models & Mechanisms (DMM), dmm.biologists.org, reveals the cellular signals which cause one treatment for kidney failure to lose its usefulness over time. Depressed dialysis patients more likely to be hospitalized or die, researcher finds Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found. Depressed dialysis patients more likely to be hospitalized or die, researcher finds Dialysis patients diagnosed with depression are nearly twice as likely to be hospitalized or die within a year than those who are not depressed, a UT Southwestern Medical Center researcher has found. Drug lowers body's 'set point' to control hyperparathyroidism in dialysis patients A medication called cinacalcet-an important part of treatment to control high levels of parathyroid hormone (PTH) in patients receiving dialysis for end-stage renal disease (ESRD)-works by resetting the balance between calcium and PTH levels, according to a study in the November Journal of the American Society of Nephrology (JASN). Researchers design model for automated, wearable artificial kidney Two researchers from UCLA and the Veterans Affairs Greater Los Angeles Healthcare System have developed a design for an automated, wearable artificial kidney, or AWAK, that avoids the complications patients often suffer with traditional dialysis. Reducing Blockage Fails to Improve Access to the Bloodstream for Kidney Dialysis Reducing early blockages in bloodstream access for kidney failure treatment does not increase the likelihood that the access will function adequately for long-term treatments, according to a study funded by the National Institutes of Health. Results were published May 14, 2008, in the Journal of the American Medical Association. Is extra-corporal liver support with prometheus safe in patients with end-stage liver disease? Patients with end-stage liver disease would benefit from liver supportive liver therapy while waiting for stabilization of hepatic functions or to enable bridging to liver transplantation. Scripps Florida scientists develop a process to disrupt hepatitis C virion production HCV is a significant human pathogen, infecting more than three percent of the world's population. The incidence of infection in the United States has been estimated to be as high as 4 million cases. Standard test for blood sugar control not accurate in diabetic dialysis patients The standard test for measuring blood sugar control in people with diabetes is not accurate in those on kidney hemodialysis, according to new research at Wake Forest University Baptist Medical Center. Americans pay the most for prescription drugs and still don't take them An international study of dialysis patients shows that although U.S. residents have the highest out-of-pocket drug costs, even those who can afford their prescription drugs are far less likely to take them than patients in other countries. More Hemodialysis Current Events and Hemodialysis News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||